微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 1.17% | -59.63% | 10.38% | 100/159 | 3.55% | 翰宇药业 | 52.19% | 行业排名> |
| 2026-06-30 | 1.06% | -51.82% | 65.37% | 98/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.64% | -39.59% | -78.91% | 97/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 3.04% | 44.08% | 4.9% | 79/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 2.9% | 51.65% | 31.73% | 87/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.2% | 115.69% | 107.35% | 79/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.06% | 212.06% | -49.72% | 78/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.11% | 348.24% | 10.41% | 85/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 1.91% | 260.57% | 87.35% | 99/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.02% | 5000% | 200% | 103/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.34% | 240% | 140% | 108/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.85% | 93.4% | -260.38% | 108/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.53% | -14.52% | 2550% | 112/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.02% | -91.3% | -80% | 114/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.1% | -54.55% | 100.78% | 116/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -12.87% | -1488.89% | -2175.81% | 128/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.62% | 113.79% | 169.57% | 111/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.23% | 146.94% | 4.55% | 113/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.22% | 123.4% | 127.16% | 110/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -0.81% | 25% | -379.31% | 114/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 0.29% | -88.35% | 159.18% | 114/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -0.49% | -388.24% | 47.87% | 117/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -0.94% | -180.34% | 12.96% | 113/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -1.08% | -152.43% | -143.37% | 113/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.49% | 49.1% | 1364.71% | 90/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.17% | -82.83% | -85.47% | 107/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 1.17% | 108.93% | -43.2% | 66/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.06% | 456.76% | 23.35% | 109/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 1.67% | 15.97% | 68.69% | 95/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.99% | 3.13% | 76.79% | 99/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.56% | 12% | 51.35% | 93/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 0.37% | -9.76% | -74.31% | 116/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.44% | 251.22% | 50% | 93/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 0.96% | 200% | 92% | 94/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.5% | 100% | 21.95% | 88/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 0.41% | 142.27% | 0% | 115/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 0.41% | -66.67% | 28.13% | 92/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.32% | -21.95% | 28% | 98/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.25% | -3.85% | 125.77% | 78/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | -0.97% | -2040% | -178.86% | 107/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.23% | 105% | 200% | 72/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 0.41% | -26.79% | 57.69% | 81/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.26% | -23.53% | 420% | 71/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |